Sex hormone blocker increases likelihood of pregnancy in breast cancer patients

31 Oct 2018


The sex hormone blocker, goserelin, protects the ovaries from breast cancer chemotherapy, improving the likelihood of future pregnancy, according to research published in the Journal of the National Cancer Institute

Science Daily


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story